CA2045950A1 - Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies - Google Patents
Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumoniesInfo
- Publication number
- CA2045950A1 CA2045950A1 CA 2045950 CA2045950A CA2045950A1 CA 2045950 A1 CA2045950 A1 CA 2045950A1 CA 2045950 CA2045950 CA 2045950 CA 2045950 A CA2045950 A CA 2045950A CA 2045950 A1 CA2045950 A1 CA 2045950A1
- Authority
- CA
- Canada
- Prior art keywords
- proteins
- cytolytic
- vaccine
- prevention
- pleuropneumoniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000204031 Mycoplasma Species 0.000 title abstract 2
- 206010035664 Pneumonia Diseases 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 201000006509 pleuropneumonia Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 108010008038 Synthetic Vaccines Proteins 0.000 title 1
- 229940124551 recombinant vaccine Drugs 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 7
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 229960005486 vaccine Drugs 0.000 abstract 5
- 230000001461 cytolytic effect Effects 0.000 abstract 4
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 abstract 3
- 239000003298 DNA probe Substances 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2045950 CA2045950C (fr) | 1991-06-28 | 1991-06-28 | Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2045950 CA2045950C (fr) | 1991-06-28 | 1991-06-28 | Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2045950A1 true CA2045950A1 (fr) | 1992-12-29 |
| CA2045950C CA2045950C (fr) | 2004-05-11 |
Family
ID=4147933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2045950 Expired - Fee Related CA2045950C (fr) | 1991-06-28 | 1991-06-28 | Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2045950C (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5925354A (en) * | 1995-11-30 | 1999-07-20 | Michigan State University | Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
| US6019984A (en) * | 1995-03-01 | 2000-02-01 | University Of Guelph | Bacterial preparations, method for producing same, and their use as vaccines |
| US6610307B1 (en) * | 1995-11-02 | 2003-08-26 | Commonwealth Scientific And Industrial Research Organisation | Immunity against pasteurella haemolytica leukotoxin |
| US6770275B1 (en) * | 1996-05-31 | 2004-08-03 | Akzo Nobel N.V. | Live attenuated RTC-producing bacteria of the family |
-
1991
- 1991-06-28 CA CA 2045950 patent/CA2045950C/fr not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6019984A (en) * | 1995-03-01 | 2000-02-01 | University Of Guelph | Bacterial preparations, method for producing same, and their use as vaccines |
| US6610307B1 (en) * | 1995-11-02 | 2003-08-26 | Commonwealth Scientific And Industrial Research Organisation | Immunity against pasteurella haemolytica leukotoxin |
| US5925354A (en) * | 1995-11-30 | 1999-07-20 | Michigan State University | Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
| US6410021B1 (en) | 1995-11-30 | 2002-06-25 | Univ Michigan State | Vaccines of pasteurellaceae mutants and vaccination method |
| US6770275B1 (en) * | 1996-05-31 | 2004-08-03 | Akzo Nobel N.V. | Live attenuated RTC-producing bacteria of the family |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2045950C (fr) | 2004-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0878545A3 (fr) | Protéines OspA des sous-groupes borrelia burgdorferi, gènes codants et vaccins | |
| EP1347055A3 (fr) | Composés et procédés pour l'immunothérapie et le diagnostic de la tuberculose | |
| CA2123579A1 (fr) | Vaccin recombinant multivalent a proteine m | |
| WO1999042588A3 (fr) | Antigenes du streptocoque du groupe b | |
| WO1998016646A3 (fr) | Composes et methodes utilises pour l'immunotherapie et le diagnostic de la tuberculose | |
| WO1998053075A3 (fr) | Composes pour l'immunotherapie et pour le diagnostic de la tuberculose et leur utilisation | |
| EP1275720A3 (fr) | Histidyl-trna synthetase de staphylococcus aureus | |
| WO1999042076A3 (fr) | Composes et methodes pour l'immunotherapie et le diagnostic de la tuberculose | |
| AU6236396A (en) | Omp26 antigen from haemophilus influenzae | |
| NO974969D0 (no) | Multimer rekombinant ureasevaksine | |
| WO2003065973A3 (fr) | Compositions de vaccins multivalents a base de streptocoques et procedes d'utilisation | |
| CA2105057A1 (fr) | Sequences d'adn codant pour les caracteres de virulence de streptococcus suis et partie de ces sequences, polypeptides et anticorps derives de ces sequences et leur utilisation pour le diagnostic des infections a s. suis et la protection des mammiferes, y compris de l'homme, contre celles-ci | |
| CA2045950A1 (fr) | Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies | |
| CA2071863A1 (fr) | Vaccin recombinant contre la pleuropneumonie porcine | |
| PT787796E (pt) | Epitopos protectores de ciclase do adenilo-hemolisina (ac-hly), sua aplicação ao tratamento ou à prevenção das infecções por bordetella | |
| CA2198743A1 (fr) | Vaccin de la peritonite infectieuse feline | |
| NZ331889A (en) | Trypanosomatids histones for use as an antigen against trypanosomatic infection, including diagnostic tests, pharmaceutical compositions and vaccines of these antigens | |
| DK0420743T3 (da) | Vaccine til beskyttelse mod svinehæmophilose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |